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Neuronal activity is critical for synaptogenesis and the development of neuronal networks. In the immature brain excitation
predominates over inhibition facilitating the development of normal brain circuits, but also rendering it more susceptible to
seizures.Inthispaper,we reviewtheevolutionofthesubunitcompositionofneurotransmitterreceptors duringdevelopment, how
itpromotesexcitationintheimmaturebrain,andhowthissubunitcompositionofneurotransmissionreceptorsmaybealsopresent
intheepilepticbrain.Duringnormalbraindevelopment,excitatoryglutamatereceptorspeakinfunctionandgamma-aminobutiric
acid(GABA)receptorsaremainlyexcitatoryratherthaninhibitory.Agrowingbodyofevidencefromanimalmodelsofepilepsyand
statusepilepticushasdemonstratedthatthebrainexposedtorepeatedseizurespresentsasubunitcompositionofneurotransmitter
receptorsthatmirrorsthatoftheimmaturebrain andpromotesfurtherseizuresand epileptogenesis.Studies performedinsamples
from the epileptic human brain have also found a subunit composition pattern of neurotransmitter receptors similar to the one
found in the immature brain. These findings provide a solid rationale for tailoring antiepileptic treatments to the specific subunit
composition of neurotransmitter receptors and they provide potential targets for the development of antiepileptogenic treatments.
1. Introduction
Neuronal activity is critical for synaptogenesis and the devel-
opment of neuronal networks. In the immature brain exci-
tation predominates over inhibition facilitating the devel-
opment of normal brain circuits. However, this tendency
towards hyperexcitability also renders it more susceptible
to seizures [1, 2]. Following prolonged seizures, the subunit
composition of neurotransmitter receptors may be similar to
that of the immature brain [1–6].
In this paper we will review the patterns of subunit
composition of the main glutamate [𝗼-amino-3-hydroxy-5-
methyl-4-isoxazolepropionicacid(AMPA)andN-methyl-D-
aspartate (NMDA)] and gamma-aminobutyric acid (GABA)
receptors during development [7–13]. We will also review
the subunit composition of neurotransmitter receptors that
m i r r o r st h a to ft h ei m m a t u r eb r a i n ,f a c i l i t a t i n gf u r t h e r
seizures and the development of pathologic neuronal net-
works [14–21]. Finally, we will discuss the novel therapeutic
targets that are being revealed by studying the subunit
composition of the neurotransmitter receptors and potential
therapeutic translation into clinical practice [3–6].
2. Subunit Composition of
Glutamate and GABAA Receptors in
the Immature Brain (Table 1)
2.1. Data from the Immature Brain in Animal Models. During
normal brain maturation, the subunit composition of the
AMPA,NMDA,andGABAA receptorsevolvesovertimeand
their function changes accordingly (Figure 1).
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Table 1: Subunit composition of glutamate and GABA receptors in the immature brain.
Author and year Study design Substudy features
(if applicable) AMPA NMDA GABA
Animal models of the immature brain without seizures
Kumar et al., 2002 [9]
Neocortical pyramidal neurons in
excitatory layer 5, immature nonepileptic
rats (compared to mature rats)
GluA2 ↓
GluA1/GluA2 ↑
GluA4/GluA2 ↑
Talos et al., 2006 [11] Immature nonepileptic rats (compared to
mature rats)
White matter
GluA1 ↓
GluA2 ↓
GluA3 ↑
GluA4 ↑
nonGluA2/GluA2 ↑
Gray matter
GluA1 ↑
GluA2 ↓
GluA3 ↓
GluA4 ↓
nonGluA2/GluA2 ↑
GluA1/GluA2 ↑
Monyer et al., 1994 [10] Immature nonepileptic rats (compared to
mature rats). Various areas in the brain
GluN2A ↓
GluN2B ↓
GluN2C ↓
GluN2D ↑
Wong et al., 2002 [13] Immature nonepileptic rats (compared to
mature rats). Various areas in the brain
GluN3A ↑
GluN3A/GluN1 ↑
Dunning et al., 1999 [22]Functional studies of neurons from
somatosensory cortex of neonatal mice 𝗼1 ↓
Data from the human immature brain without seizures
Talos et al., 2006 [12]
Autopsy samples from newborns of
different gestational ages (compared to
adult standard). Parietooccipital lobe
tissue. Death due to nonneurological
disorders
White matter
GluA2 ↓
GluA1/GluA2 ↑
GluA3 ↑
GluA3/GluA2 ↑
GluA4 ↑
GluA4/GluA3 ↑
Gray matter
GluA1 ↑
GluA2 ↓
GluA1/GluA2 ↑
GluA3 ↓
GluA4 ↓
Brooks-Kayal and
Pritchett, 1993 [7]
Autopsy samples from patients without
neurological disease of different ages (36
gestational weeks to 81 years). Frontal
cortex and cerebellum
𝗼1 ↓
𝗼1 ↓
∗
∗Studies on mRNA.
2.1.1. AMPA Receptors. Reduced expression of the GluA2
s u b u n i ti nA M P Ar e c e p t o r sl e a d st oa ni n c r e a s e dp e r m e -
ability to Ca
2+ contributing to a lower threshold for seizures
[2,9,24,25].AMPAreceptorswithouttheGluA2subunitare
typically expressed in the immature brain and their presence
corresponds to an increased risk of excitotoxic cellular injury
due to hypoxia-ischemia and of subsequent epileptogenesis
both in rats and in humans [11, 12]. Knockout models of
the GluA2 subunit lead to reduced seizure threshold and
seizure-like behavior and, therefore, supports the hypothesis
that AMPA receptors without the GluA2 subunit promote
hyperexcitability [26].
2.1.2. NMDA Receptors. I nr a tm o d e l so ft h ei m m a t u r e
brain GluN2B, GluN2C, GluN2D, and GluN3A subunits are
overexpressed and this overexpression, which increases the
ratio non-GluN2A/GluN2A, promotes hyperexcitability [1,
13, 25, 27].
2.1.3. GABA𝐴 Receptors and the Transporter of Chloride.
Contrary to what happens in mature neurons, in developing
neurons the concentration of chloride (Cl
−) is higher in the
intracellular than in the extracellular space [28–30]. As a
result, opening of GABAA receptor associated Cl
− channel
leads to different effects during development: an efflux ofBioMed Research International 3
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Figure 1: Evolution of neurotransmitter receptors expression over
development. During the critical period (shaded rectangle), exci-
tatory receptors are overexpressed, and inhibitory receptors are
underexpressed compared to any other period of life. Approx-
imate human ages are expressed in years (x-axis, upper row)
and approximate rodent ages are expressed as postnatal days
(x-axis, lower row). Legend: AMPA: alpha-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid. GABA: gamma-aminobutyric
acid.NMDA:N-methyl-D-aspartate(adaptedwithpermissionfrom
Rakhade and Jensen [1], by permission of Macmillan Publishers,
Ltd., © 2009).
Cl
− and depolarization (excitation) in the immature neuron
and an influx of Cl
− and hyperpolarization (inhibition) in
t h em a t u r en e u r o n( Figure 2)[ 28–30]. Cl
− concentration
is mainly regulated by the action of the Cl
− transporters
NKCC1 and KCC2. NKCC1 accumulates Cl
− in the cell and
KCC2 transports Cl
− o u to ft h ec e l l .N K C C 1i st h em a i n
Cl
− transporter in the immature neuron and its expression
decreases over time while KCC2 is increasingly expressed
during brain development [28, 29, 31–33]. KCC2 is the
primary determinant of the changes in the gradients of
Cl
− concentration during neuronal development and of the
resulting maturation (from excitatory towards inhibitory) of
GABAergicneurotransmission[32,33].Whilethemajorstep
during the maturation of GABAA neurotransmission occurs
during the shift in intraneuronal Cl
− concentration, changes
inthesubunitcompositionofGABAAreceptorsmayalsoplay
ar o l e .S p e c i fi c a l l y ,t h e𝗼1s u b u n i to ft h eG A B A A receptor is
developmentally regulated and expressed at low levels in the
immature brain [22].
2.2. Data from the Immature Human Brain
2.2.1. AMPA Receptors. When the ratio non-GluA2/GluA2
is elevated, the permeability to Ca
2+ increases and this
promotes hyperexcitability [34]. A pathologic study using
immunoblotting and immunofluorescence compared the
subunit composition of AMPA receptors of adults to that
of fetuses, stillbirths, and newborns (gestational ages from
18 to 41 weeks). All of the study subjects died from non-
neurological causes and presented no brain lesions or brain
malformations. The non-GluA2/GluA2 ratio was elevated in
fetuses, stillbirths, and newborns when compared to adults.
In addition, this ratio peaked during early fetal development
a n dp r e t e r mp e r i o di nt h ew h i t em a t t e ra n dd u r i n gt e r m
and neonatal periods in the brain cortex, that is, during the
periods of greater susceptibility to hypoxic-ischemic lesions
in each component of the brain matter [12].
2.2.2. GABA𝐴 Receptors. In a series of patients who died
withoutneurologicaldiseasesatdifferentages(from36weeks
of gestational age to 81 years), the subunit composition
of the GABAA receptor was evaluated both by binding to
benzodiazepines and by mRNA expression. A low level of
expression of the 𝗼1 subunit was found in the immature (as
compared to the mature) brain [7].
In summary, the immature brain has an increase of the
following ratios: GluA1/GluA2 (AMPA receptors), GluN2B/
GluN2A(NMDA receptors),NKCC1/KCC2 (GABAA neuro-
transmission), and non-𝗼1/𝗼1( G A B A A receptors) that pro-
mote hyperexcitability, synaptogenesis, and the development
of normal neuronal networks in the developing brain [7, 9–
13, 22]. A summary including the main features of the above-
mentioned studies can be found in Table 1.
3. Subunit Composition of Glutamate and
GABA Receptors in the Brain Submitted to
Seizures (Table 2)
The subunit composition of neurotransmitter receptors in
epilepsy and status epilepticus mirrors that of the immature
brain [14–21]. Different animal models have shown that
the brain exposed to recurrent seizures has an “immature”
neurotransmission that may promote further seizures and
epileptogenesis [14, 19]. These findings have been replicated
in human brain tissue collected during epilepsy surgery [15–
17, 20, 21].
3.1. Data from the Epileptic Brain in Animal Models
3.1.1. AMPA Receptors. In a study of adult rats with
pilocarpine-induced status epilepticus, the expression of
surface GluA2 AMPA subunit was reduced [23]. In addition
to changes in subunit composition, in a study of 4–7-week-
old rats, AMPA receptors moved towards the cell surface
and towards synapses during prolonged seizures further
promoting an excitatory environment and self-sustaining
seizures [35].
3.1.2. NMDA Receptors. Inaninvitropreparationofthehip-
pocampusfrom4-day-oldrats,theinductionofsynchronized
network discharges led to reduction in the expression of the
subunits of the NMDA receptor, especially, a reduction of
the GluN2A subunit [18]. In a 10-day-old rat model, tetanus
toxin-induced seizures led to reduction in GluN1, GluN2A,
andGluN2Bsubunits[19].Ina9-to13-day-oldmousemodel,4 BioMed Research International
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Figure 2: Effect of the opening of the GABAA receptor associated channel. (a) In the immature neuron, the concentration of Cl
− is higher in
the intracellular space and, therefore, the opening of the channel leads to an efflux of Cl
− and depolarization (excitation). (b) In contrast, in
the mature neuron, the concentration of Cl
− is higher in the extracellular space and, therefore, the opening of the channel leads to an influx
of Cl
− and hyperpolarization (inhibition). Legend: Cl
−: chloride. IN: intracellular. EX: extracellular.
flurothyl-inducedseizurescausedareductionoftheGluN2A
subunit [19].
3.1.3. GABA𝐴 Receptors. In an adult rat model, the whole-
cell patch-clamp recording technique showed that, following
pilocarpine-inducedstatusepilepticus,hippocampalneurons
had GABAA receptors with functional characteristics that
promoted hyperexcitability [14]. This functional change was
accompanied by a change in mRNA expression: mRNA for
𝗼1 subunits was decreased while mRNA for non-𝗼1s u b u n i t s
was increased [14]. This increase in the ratio of the mRNA
for non-𝗼1/𝗼1 subunits was present soon after pilocarpine-
inducedstatusepilepticusandalsoseveralmonthslater,when
t h er a t sh a dd e v e l o p e ds p o n t a n e o u st e m p o r a ll o b es e i z u r e s ,
suggesting that the increased ratio in the non-𝗼1/𝗼1s u b u n i t s
is a common pathologic mechanism that occurs following
seizures, regardless of etiology and duration [14]. In addition
to changes in subunit composition, GABAA receptors move
awayfromsynapsesduringprolongedseizures,increasingthe
excitatory/inhibitory balance and promoting self-sustaining
SE [36].
3.2. Data from the Epileptic Human Brain
3.2.1. Origin of the Human Brain Samples: Epilepsy Surgery
for Difficult-to-Control Seizures. Despite the large amount of
data on subunit composition of glutamate and GABA recep-
tors coming from the study of animal models of epilepsy,
a validation in human brain tissue was necessary in order
to apply these results into clinical practice [8, 14, 18, 19]. A
major limitation to reproduce these studies in humans was
theavailabilityoffreshhumanbraintissue.However,epilepsy
surgery has emerged as a useful therapeutic option for
selectedpatientswithrefractoryformsofepilepsy[37,38]and
it has opened a unique opportunity for the study of subunits
in neurotransmitter receptors in the human brain [15–17, 20,
21, 37, 38]. The samples of fresh human brain tissue come
from patients who underwent epilepsy surgery because of a
heterogeneous group of epilepsy etiologies such as tuberous
sclerosis complex [17, 20, 21]a n do t h e rm a l f o r m a t i o n so f
cortical development [15–17] and from patients with epilepsy
ofunknownetiology[15–17,20].Controltissueusuallycomes
from autopsies of subjects who died from nonneurological
causes [15, 17, 20, 21].
3.2.2. Data from Patients with Tuberous Sclerosis Complex
(TSC). InpatientswithTSC,thesubunitcompositionofneu-
rotransmitter receptors mirrors that of the immature brain
and may substantially contribute to increased network
excitability in tubers and perituberal tissue [20, 21].
In an epilepsy surgery series, subunit composition of
glutamate and GABAA r e c e p t o r sw a se v a l u a t e di np a t i e n t s
with TSC, in cortex from epileptic patients without TSC, and
in a control group of autopsy subjects without neurological
diseases [20]. Brain tissue from TSC patients showed an
elevationoftheGluA1/GluA2ratio(AMPAreceptors)andan
increaseinGluN2BandGluN3Asubunits(NMDAreceptors)
[20]. Cortex tissue from patients with epilepsy without TSC
showed the same pattern of elevated GluA1/GluA2 ratio
(AMPA receptors) and an increase in GluN2B and GluN3A
subunits (NMDA receptors) [20].
In another study of human brain tissue, subunit compo-
sition was evaluated in patients with TSC, in cortex from
epileptic patients without TSC, and in a control group of
autopsy subjects without neurological diseases [21]. Patch-
clamp studies of dysplastic neurons from patients with TSCBioMed Research International 5
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showedafunctionalhyperexcitabilityoftheGABAA receptor
[21]. Brain tissue from TSC patients and patients with focal
corticaldysplasiatypeIIbshowedreductioninthe𝗼1subunit
(GABAA receptors) [21]. In addition, in patients with TSC
and focal cortical dysplasia type IIb the expression of the Cl
−
transporters mirrored that of the immature brain: increased
NKCC1 and decreased KCC2 [21].
Takentogether,thesedatashowthatinpatientswithTSC
theneuronslocatedinthetubersandintheperituberaltissue
present a subunit receptor composition that mirrors that of
the immature brain [20, 21].
3.2.3. Data from Patients with Malformations of Cortical
Development. Brain samples from patients with other mal-
formationsofcorticaldevelopmentalsopresentanimmature
subunit composition of neurotransmitter receptors [15, 16].
In a study of mRNA expression in neurons from patients
with malformations of cortical development, dysplastic neu-
rons presented a reduction in mRNA expression for the
GluA1 subunit and an elevation in the mRNA expression
for the GluA4 subunit (AMPA receptor), an increase in the
mRNA expression ratio for the GluN2B/GluN2A subunits
(NMDA receptor), and a reduction in the mRNA expression
for the 𝗼1 subunit (GABAA receptor) [15]. In this same study,
heterotopic,nondysplasticneuronsshowedareductioninthe
mRNA expression for the GluA1 subunit (AMPA receptor)
a n dar e d u c t i o ni nt h em R N Ae x p r e s s i o nf o rt h e𝗼1s u b u n i t
(GABAA receptor) [15].
In another study on the subunit composition of the
NMDA receptors performed in patients with malformations
of cortical development, tissue from focal cortical dysplasia
showed increased GluN2B subunit and tissue from periven-
tricular nodular heterotopia showed a reduction of GluN1,
GluN2A, and GluN2B [16].
Taken together, these data point towards an immature
subunit composition of neurotransmitter receptors in the
abnormal, epilepsy-prone brain tissue of malformations of
cortical development [15, 16].
3.2.4. Data from Convulsive Status Epilepticus and from
Electrical Status Epilepticus in Sleep. In vitro and in vivo
animal models of refractory epilepsy and refractory status
epilepticus have demonstrated that seizures, especially dur-
ing early life, modify the expression patterns of glutamate
and GABAA receptors further enhancing hyperexcitability
and leading to a brain tissue with a lower threshold for
subsequent recurrent seizures and status epilepticus [1, 2,
8, 14, 18, 19, 39]. However, reproduction of these results in
t h eh u m a nb r a i nh a sb e e nl i m i t e db e c a u s eo ft h el i m i t e d
availability of fresh brain tissue from patients with refractory
epilepsy and refractory status epilepticus. A recent study has
compared the subunit composition of glutamate and GABA
receptors in brain samples from (i) patients with refractory
convulsive status epilepticus, (ii) patients with refractory
electrical status epilepticus during sleep (ESES), and (iii)
patients with refractory epilepsy to the subunit composition
neurotransmitterreceptorsofacontrolgroupofsubjectswho
died of nonneurological causes [17]. Patients with refractory
status epilepticus showed an increase in GluN2B subunit and
GluN2B/GluN2Aratio(NMDAreceptors)andanincreasein
the 𝗼2/𝗼1 ratio (GABAA receptors) [17]. Tissue from patients
with refractory ESES showed an elevation of the GluA1
subunitandoftheGluA1/GluA2ratio(AMPAreceptors)and
increased GluN2B/GluN2A ratio (NMDA receptors) [17].
Brain samples from patients with refractory epilepsy showed
anelevationoftheGluA1/GluA2ratio(AMPAreceptors)and
an elevation of the 𝗼2/𝗼1 ratio (GABAA receptor) [17]. The
mRNAexpressionwasalsoanalyzed;patientswithrefractory
convulsive status epilepticus had an elevation of the mRNA
expressionforthe𝗼2subunit(GABAA receptor) and patients
withrefractoryepilepsyhadanelevationofthemRNAforthe
𝗼2s u b u n i ta n do ft h e𝗼2/𝗼1 ratio (GABAA receptor) [17]. All
t h ec h a n g e sf o u n di ns u b u n i tc o m p o s i t i o no fg l u t a m a t ea n d
GABAA receptors were consistent with “immature” “hyper-
excitable” receptors, although because of low numbers only
the above-mentioned cases reached statistically significant
differences [17].
4. Limitations of the Studies on Subunit
Composition of Neurotransmitter Receptors
4.1. Technical Limitations
4.1.1. Immunofluorescence. Immunofluorescence identifies
the individual subunit of interest in brain slices. This method
provides information on the general distribution of the
individual subunits in the brain. However, limitations of this
technique include the unreliability of the calculation of the
levelsofexpressionoftheindividualsubunits,and,therefore,
it is impossible to compare the relative levels of expression of
the different subunits from the same receptor.
4.1.2. Subunit Levels of Expression. Immunofluorescence is
often complemented with Western blotting [11, 12, 20, 21],
a technique that allows calculating the levels of expression
of neurotransmitter receptors and estimating the relative
ratio of different subunits. However, subunit composition
i ss t u d i e di nt i s s u es a m p l e sa n d ,t h e r e f o r e ,i t sl e v e l so f
expression not only reflect the levels of expression in the
cellular membrane but also reflect its levels of expression in
organelle’s membranes. That is, a particular subunit could
appear at normal levels in the studied tissue, but its levels
of expression in the cellular membrane may be low (or
high) because the subunit is kept in the membranes of the
internal organelles [40]. Curiously, after a single episode
of kainate-induced seizures in immature rats, there is a
long-term shift of GluA1 receptor from the membrane to
the intracellular compartment and a loss of total GluN2A
in the rat hippocampus [40], changes that may increase
hyperexcitability of the cellular membrane, but that would be
undetectablewhenstudyingglobaltissuelevelsofexpression.
4.1.3. Timeline in the Evaluation of the Level of Expression
of Subunit Composition of Neurotransmitter Receptors. Most
studies present the results of changes in subunit composition
of neurotransmitter receptors at a single point in time.8 BioMed Research International
Frequently, results refer to the acute-subacute period after
seizure induction. Some series have a longer follow-up after
seizure induction. Only a few report both results in the short
and long term after seizure induction [14]a n dv e r yf e w
report changes in neurotransmitter receptors over time [41].
Despite the fact that the timeline for follow-up was different
in various studies, we found a relatively consistent pattern of
subunitcompositionchangesinstudieswithdifferentfollow-
up periods (Tables 1 and 2).
4.2. Limitations of the Studies in Animal Models
4.2.1. Seizures Induced in the Immature Brain versus Seizures
Induced in the Adult Brain. The age at which seizures
are induced in animal models may influence the resulting
changes in the subunit compositions. In fact, some animal
models have demonstrated opposite changes in subunit
expression in immature and adult animals [26]. However,
most results show similar results in the immature and adult
animal model (Tables 1 and 2).
4.2.2.ExperimentallyInducedSeizuresversusNaturallyOccur-
ring Seizures. Studies using animal models are based on
the assumption that experimentally-induced seizures have a
similar effect on the brain than naturally-occurring seizures.
This assumption has been largely confirmed in most aspects
of epilepsy research such as epileptogenesis [1]. However,
to safely translate animal research findings into changes in
clinicalpracticeconfirmationofresultsinhumanbraintissue
is warranted.
4.2.3. Applicability of Results from Animal Models to the
Human Brain. The subunit composition of the “immature”
a n d“ h y p e r e x c i t a b l e ”A M P Ar e c e p t o rs h o w sa ne l e v a t i o no f
the non-GluA2/GluA2 ratio both in animal models [9, 11]
and in studies of the human brain [12, 17, 20]. The subunit
compositionofthe“immature”and“hyperexcitable”GABAA
receptor shows an elevation of the non-𝗼1/𝗼1 ratio both in
animalmodels[14]andinstudiesofthehumanbrain[17,21].
In contrast, the “immature” and “hyperexcitable” NMDA
receptor has a decreased GluN2B subunit in rodent models
[18, 19], while in humans the GluN2B subunit is elevated
[15–17, 20]. The non-GluN2A/GluN2A ratio likely remains
elevated in all these models.
4.3. Limitations of Human Brain Tissue Studies
4.3.1. Heterogeneous Etiologies and Clinical Syndromes.
Human brain tissue is collected from patients who undergo
epilepsy surgery because of refractory epilepsy. Contrary
to the animal models, the underlying etiology of refractory
epilepsy is heterogeneous: malformations of cortical devel-
opment, tubers from patients with TSC, or refractory
epilepsy without an underlying structural etiology, among
others [15–17, 20, 21]. Even within one broad category,
such as malformation of cortical development, there is a
wide variability of underlying pathologies with different
patients presenting with different types of malformations.
In addition, different cell populations from the same lesion
are heterogeneous and may present with different patterns
of subunit composition of neurotransmitter receptors
[15, 16, 20].
4.3.2. Limitations of the Control Subjects. Ideally, the best
control tissue for patients that undergo epilepsy surgery
should be a sample from the corresponding brain region in a
nonepileptic and healthy subject of the same age. Obviously,
t h a tk i n do fc o n t r o lt i s s u ei sn o ta v a i l a b l ei nh u m a nb r a i n
studies. Control tissue usually comes from autopsies of
subjects who died from nonneurological causes [15, 17, 20,
21] .Ar a r e rs o u r c eo fh u m a nb r a i nt i s s u et ob eu s e da s
controltissueistheperitumoraltissueresectedduringtumor
resection surgery [16].
4.3.3. Limitations Associated with Heterogeneous Sampling
Site. Thelocalizationofthebraintissuetoberesectedduring
surgery is decided pursuing the best interest of the patient.
Therefore, this area is different among different patients
and it is usually different from the area collected during
autopsy in controls [16, 20, 21]. Potential regional variations
intheexpressionofsubunitcompositionofneurotransmitter
receptors may compromise comparability of results.
Despite all the sources of heterogeneity most studies
point in the same direction; subunit composition of neuro-
transmitter receptors in epileptic tissue mirrors that of the
immature brain and promotes further hyperexcitability and
epileptogenesis.Therefore,itseemsreasonabletohypothesize
thatthe“immature”subunitcompositionofneurotransmitter
receptors is a common pathway that appears in response
to seizures regardless of the etiology, clinical syndrome, or
sampled brain area.
4.3.4.NumberofStudySubjects. Thepreviouslimitationscan
be potentially overcome if there were enough study subjects
to compare the different subgroups (e.g., only patients with
status epilepticus secondary to focal cortical dysplasia in
the temporal lobe). However, collection of a large number
of human brain samples is limited by ethical and practical
r e a s o n s .H u m a ns e r i e so nt h i st o p i cm o s tf r e q u e n t l yc o n s i s t
of less than 10 patients in each group [15–17, 20, 21]. Even
a large autopsy study of perinatal patients who died of
nonneurologicalcauses ina largereferencehospitalcollected
“only” 43 patients and 3 adult controls [12]. Taken together,
these data highlight that even for large reference centers it is
n o tf e a s i b l et oc o l l e c te n o u g hp a t i e n t st of u r t h e rd e v e l o pt h i s
line of research.
5. Outlook: The Need for
Multicenter Collaboration
Collecting a very large number of brain samples with homo-
geneous pathology and comparable characteristics is not a
feasiblegoalforanyindividualhospitalorgroupofhospitals.
Only a multicenter collaboration with the development of
nationalorinternationalcentralizedtissuebanksmaysumup
t h en u m be r sn e c e s s a ryt oa c h i ev et h i sg o a l .Th eU n i v e r s i t yo fBioMed Research International 9
Maryland Tissue Bank is a human brain samples repository
thatiscurrentlycollectingbraintissuesamplesfromdifferent
p a t h o l o g i e sa n dm a yb eu s e f u lf o rt h es t u d yo fs u b u n i t
composition of neurotransmitter receptors in epilepsy.
6. Clinical Implications
In the developing brain there is a predominance of excitation
over inhibition in order to meet the needs of the rapid
developmentofsynapsesandneuronalnetworks(Figure 1)[1,
2, 42]. This tendency towards hyperexcitability is reflected in
the subunit composition of the normal immature brain both
inanimalmodels[9–11,13]a ndinsa m p lesfr o mtheperina tal
human brain [12]. As the brain matures and the need for the
development of synapses and neuronal networks decreases,
the tendency towards hyperexcitability decreases and the
subunit composition changes and acquires its adult features
(Figure 1)[ 1, 2]. However, when exposed to repeated seizure
activity, the brain tissue goes back to a subunit composition
and distribution of neurotransmitter receptors that mirrors
that of the immature brain and the enhanced synaptogenesis
promotes the development of pathologic neuronal networks
(epileptogenesis) [1, 2, 43, 44].
Differences in neurotransmission should be taken into
account when treating epileptic patients. Antiepileptic med-
ications act differently in the mature and immature brain
tissue. As an example, GABAergic anticonvulsants such as
phenobarbital and benzodiazepines can have a dual action in
the immature brain: both excitatory and inhibitory [4]. The
excitatory response is secondary to the high concentration
of intracellular Cl
− in the immature neuron mainly due to
the action of the NKCC1 transporter that accumulates Cl
−
intracellularly[28–30].BlockingtheNKCC1transporterwith
bumetanideenabledtheantiepilepticactionofphenobarbital
in vitro [3]. Similarly, in an in vitro model of seizures,
phenobarbitalwasabletocontrolseizureswhenappliedfrom
the start but aggravated seizure activity when applied after
repeated seizures (that had probably changed the chloride
concentrations in the affected neurons) [6]. Application of
bumetanide in this model prevented the paradoxical actions
of phenobarbital [6] and trials are ongoing in an attempt to
translate findings into neonates. Taken together, these results
suggest that the knowledge on the subunit composition
of neurotransmitter receptors may allow the development
of a targeted, pathophysiology-based use of antiepileptic
medications.
Another example of the application of this knowledge
into clinical practice is status epilepticus; status epilepticus
responds to most agents early in the course of the disease but
tends to be quite refractory once it is established [36, 45–48].
During status epilepticus benzodiazepine sensitive GABAA
receptors are believed to move from the synaptic mem-
brane to the cytoplasm where they are functionally inactive
while NMDA and AMPA receptors move from subsynaptic
sites to the synaptic membrane [36, 45–48]. In addition,
refractory status epilepticus promotes the development of a
subunit composition of neurotransmitter receptors pattern
thatmirrorsthatoftheimmaturebrain[17].Theseunderlying
molecular mechanisms are consistent with findings in exper-
imentalmodelsthatGABAergicantiepilepticdrugslosetheir
efficacy early in the course of status epilepticus [49]b u t
NMDA receptor blockers suppress seizures even late in the
evolution of status epilepticus [5]. As a consequence, NMDA
receptor blockers were proposed as the optimal therapy for
refractorystatusepilepticus,withsomesuccess[5].Adetailed
knowledge of the underlying pathophysiology may allow
development of more individualized treatment strategies.
The study of the subunit composition of the neurotrans-
mitter receptors in the epileptic brain is a developing field of
research that promises to provide new therapeutic targets for
seizures and epileptogenesis.
7. Conclusion
The subunit composition of neurotransmitter receptors pro-
motes excitation over inhibition in the developing brain.
Because neuronal activity is critical for synaptogenesis and
thedevelopmentofnormalneuronalnetworks,thistendency
towards excitation facilitates the development of normal
brain circuits. Under conditions of repeated epileptiform
activity, the subunit composition of AMPA, NMDA, and
GABA receptors is similar to that of the developing brain,
promoting further seizures and the development of patho-
logical neuronal networks (epileptogenesis). This developing
field of research promises to unravel new therapeutic targets
for the treatment of seizures and epileptogenesis.
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